Nisa Investment Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.5K | Buy |
1,779
+1,294
| +267% | +$11.7K | ﹤0.01% | 2118 |
|
|
2025
Q4 | $3.26K | Sell |
485
-1,146
| -70% | -$8.64K | ﹤0.01% | 2529 |
|
|
2025
Q3 | $14.1K | Buy |
1,631
+24
| +1% | +$187 | ﹤0.01% | 2141 |
|
|
2025
Q2 | $10.1K | Buy |
1,607
+268
| +20% | +$1.77K | ﹤0.01% | 2262 |
|
|
2025
Q1 | $8.58K | Buy |
1,339
+152
| +13% | +$1.26K | ﹤0.01% | 2135 |
|
|
2024
Q4 | $9.54K | Sell |
1,187
-22,262
| -95% | -$215K | ﹤0.01% | 2145 |
|
|
2024
Q3 | $296K | Buy |
23,449
+21,635
| +1,193% | +$279K | ﹤0.01% | 1186 |
|
|
2024
Q2 | $23K | Buy |
1,814
+1,150
| +173% | +$11.6K | ﹤0.01% | 1897 |
|
|
2024
Q1 | $3.17K | Buy |
664
+164
| +33% | +$761 | ﹤0.01% | 2168 |
|
|
2023
Q4 | $2.4K | Sell |
500
-104
| -17% | -$637 | ﹤0.01% | 2172 |
|
|
2023
Q3 | $4.37K | Buy |
604
+36
| +6% | +$288 | ﹤0.01% | 2297 |
|
|
2023
Q2 | $4.22K | Sell |
568
-5,232
| -90% | -$41.1K | ﹤0.01% | 2335 |
|
|
2023
Q1 | $40K | Buy |
5,800
+3,900
| +205% | +$35.9K | ﹤0.01% | 1781 |
|
|
2022
Q4 | $20K | Sell |
1,900
-1,100
| -37% | -$19.4K | ﹤0.01% | 2060 |
|
|
2022
Q3 | $62K | Buy |
3,000
+2,913
| +3,348% | +$126K | ﹤0.01% | 1663 |
|
|
2022
Q2 | $4K | Hold |
87
| – | – | ﹤0.01% | 2299 |
|
|
2022
Q1 | $6K | Sell |
87
-8,437
| -99% | -$752K | ﹤0.01% | 2293 |
|
|
2021
Q4 | $799K | Sell |
8,524
-6,457
| -43% | -$1.11M | 0.01% | 891 |
|
|
2021
Q3 | $3.11K | Sell |
14,981
-338
| -2% | -$74.5K | 0.02% | 586 |
|
|
2021
Q2 | $3.25K | Sell |
15,319
-2,100
| -12% | -$385K | 0.02% | 585 |
|
|
2021
Q1 | $3.16K | Sell |
17,419
-1,250
| -7% | -$249K | 0.02% | 590 |
|
|
2020
Q4 | $2.08M | Buy |
18,669
+10,027
| +116% | +$1.07M | 0.01% | 681 |
|
|
2020
Q3 | $936K | Buy |
8,642
+8,187
| +1,799% | +$997K | 0.01% | 828 |
|
|
2020
Q2 | $38K | Buy |
455
+75
| +20% | +$2.87K | ﹤0.01% | 1642 |
|
|
2020
Q1 | $5K | Buy |
+380
| New | +$3.21K | ﹤0.01% | 1952 |
|
|
2019
Q1 | – | Sell |
-184
| Closed | -$7K | – | 2040 |
|
|
2018
Q4 | $7K | Hold |
184
| – | – | ﹤0.01% | 1729 |
|
|
2018
Q3 | $7K | Sell |
184
-213
| -54% | -$6K | ﹤0.01% | 1812 |
|
|
2018
Q2 | $11K | Buy |
397
+182
| +85% | +$6.15K | ﹤0.01% | 1710 |
|
|
2018
Q1 | $9K | Buy |
+215
| New | +$8.64K | ﹤0.01% | 1687 |
|
|
2017
Q2 | – | Sell |
-275
| Closed | -$7K | – | 1854 |
|
|
2017
Q1 | $7K | Buy |
+275
| New | +$7.56K | ﹤0.01% | 1761 |
|
|
2016
Q3 | – | Sell |
-170
| Closed | -$25K | – | 1862 |
|
|
2016
Q2 | $25K | Hold |
170
| – | – | ﹤0.01% | 1536 |
|
|
2016
Q1 | $18K | Buy |
+170
| New | +$18.2K | ﹤0.01% | 1643 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Nisa Investment Advisors's NVAX Position: Q1 2026 in Review
Nisa Investment Advisors increased its Novavax (NVAX) stake by 267% in Q1 2026, buying an estimated $11.7K and bringing the position to 1,779 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2118.
Nisa Investment Advisors first reported a position in NVAX in Q1 2016 and has held it in 32 quarters since. The position peaked at $2.08M in Q4 2020. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Nisa Investment Advisors held 1,779 shares of Novavax worth $14.5K as of Q1 2026.
- Nisa Investment Advisors bought 1,294 Novavax shares in Q1 2026, an estimated $11.7K.
- Novavax made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2118 holding.
- Nisa Investment Advisors first reported a position in Novavax in Q1 2016 and has held it in 32 quarters since.
- Nisa Investment Advisors's Novavax position peaked at $2.08M in Q4 2020.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.